Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1971 2
1972 2
1976 2
1977 3
1978 6
1979 2
1980 2
1981 3
1982 9
1983 1
1984 6
1985 7
1986 11
1987 11
1988 22
1989 19
1990 13
1991 15
1992 11
1993 14
1994 14
1995 10
1996 20
1997 14
1998 9
1999 11
2000 8
2001 20
2002 6
2003 10
2004 14
2005 11
2006 15
2007 10
2008 18
2009 5
2010 5
2011 8
2012 5
2013 9
2014 10
2015 5
2016 5
2017 11
2018 12
2019 10
2020 8
2021 6
Text availability
Article attribute
Article type
Publication date

Search Results

440 results
Results by year
Filters applied: . Clear all
Page 1
Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells.
Ma C, Han M, Heinrich B, Fu Q, Zhang Q, Sandhu M, Agdashian D, Terabe M, Berzofsky JA, Fako V, Ritz T, Longerich T, Theriot CM, McCulloch JA, Roy S, Yuan W, Thovarai V, Sen SK, Ruchirawat M, Korangy F, Wang XW, Trinchieri G, Greten TF. Ma C, et al. Among authors: berzofsky ja. Science. 2018 May 25;360(6391):eaan5931. doi: 10.1126/science.aan5931. Science. 2018. PMID: 29798856 Free PMC article.
Tissue-Specific Roles of NKT Cells in Tumor Immunity.
Terabe M, Berzofsky JA. Terabe M, et al. Among authors: berzofsky ja. Front Immunol. 2018 Aug 15;9:1838. doi: 10.3389/fimmu.2018.01838. eCollection 2018. Front Immunol. 2018. PMID: 30158927 Free PMC article. Review.
Cancer vaccine strategies: translation from mice to human clinical trials.
Berzofsky JA, Terabe M, Trepel JB, Pastan I, Stroncek DF, Morris JC, Wood LV. Berzofsky JA, et al. Cancer Immunol Immunother. 2018 Dec;67(12):1863-1869. doi: 10.1007/s00262-017-2084-x. Epub 2017 Nov 15. Cancer Immunol Immunother. 2018. PMID: 29143114 Free PMC article. Review.
Retraction.
Arichi T, Saito T, Major ME, Belyakov IM, Shirai M, Engelhard VH, Feinstone SM, Berzofsky JA. Arichi T, et al. Among authors: berzofsky ja. Proc Natl Acad Sci U S A. 2001 May 8;98(10):5943. doi: 10.1073/pnas.101132998. Epub 2001 May 1. Proc Natl Acad Sci U S A. 2001. PMID: 11331781 Free PMC article. No abstract available.
Therapies for tuberculosis and AIDS: myeloid-derived suppressor cells in focus.
Dorhoi A, Kotzé LA, Berzofsky JA, Sui Y, Gabrilovich DI, Garg A, Hafner R, Khader SA, Schaible UE, Kaufmann SH, Walzl G, Lutz MB, Mahon RN, Ostrand-Rosenberg S, Bishai W, du Plessis N. Dorhoi A, et al. Among authors: berzofsky ja. J Clin Invest. 2020 Jun 1;130(6):2789-2799. doi: 10.1172/JCI136288. J Clin Invest. 2020. PMID: 32420917 Free article. Review.
Labeling Extracellular Vesicles for Nanoscale Flow Cytometry.
Morales-Kastresana A, Telford B, Musich TA, McKinnon K, Clayborne C, Braig Z, Rosner A, Demberg T, Watson DC, Karpova TS, Freeman GJ, DeKruyff RH, Pavlakis GN, Terabe M, Robert-Guroff M, Berzofsky JA, Jones JC. Morales-Kastresana A, et al. Among authors: berzofsky ja. Sci Rep. 2017 May 12;7(1):1878. doi: 10.1038/s41598-017-01731-2. Sci Rep. 2017. PMID: 28500324 Free PMC article.
Strategies for developing and optimizing cancer vaccines.
Maeng HM, Berzofsky JA. Maeng HM, et al. Among authors: berzofsky ja. F1000Res. 2019 May 13;8:F1000 Faculty Rev-654. doi: 10.12688/f1000research.18693.1. eCollection 2019. F1000Res. 2019. PMID: 31131086 Free PMC article. Review.
Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank.
Chuntova P, Chow F, Watchmaker PB, Galvez M, Heimberger AB, Newell EW, Diaz A, DePinho RA, Li MO, Wherry EJ, Mitchell D, Terabe M, Wainwright DA, Berzofsky JA, Herold-Mende C, Heath JR, Lim M, Margolin KA, Chiocca EA, Kasahara N, Ellingson BM, Brown CE, Chen Y, Fecci PE, Reardon DA, Dunn GP, Liau LM, Costello JF, Wick W, Cloughesy T, Timmer WC, Wen PY, Prins RM, Platten M, Okada H. Chuntova P, et al. Among authors: berzofsky ja. Neuro Oncol. 2021 Mar 25;23(3):356-375. doi: 10.1093/neuonc/noaa277. Neuro Oncol. 2021. PMID: 33367885 Review.
Phase I study of GC1008 (fresolimumab): a human anti-transforming growth factor-beta (TGFβ) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma.
Morris JC, Tan AR, Olencki TE, Shapiro GI, Dezube BJ, Reiss M, Hsu FJ, Berzofsky JA, Lawrence DP. Morris JC, et al. Among authors: berzofsky ja. PLoS One. 2014 Mar 11;9(3):e90353. doi: 10.1371/journal.pone.0090353. eCollection 2014. PLoS One. 2014. PMID: 24618589 Free PMC article. Clinical Trial.
440 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page